United States · FDA National Drug Code directory
dapagliflozin and metformin hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-621_a54a2b85-619a-4bb8-b3fa-dfe945a9008d
- Product NDC
- 67877-621
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- dapagliflozin and metformin hydrochloride
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260406
- Source listing expiry
- 20271231
Source-listed ingredients
- DAPAGLIFLOZIN — 10 mg/1
- METFORMIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-621-05) · 67877-621-05
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-621-30) · 67877-621-30
- 10 BLISTER PACK in 1 CARTON (67877-621-38) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 67877-621-38
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →